StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening

  StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services.  Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the…

For More Information

2022 Advanced Therapies Week Audiogram

Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week. Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how you choose…

For More Information

Biocom California Member Spotlight

Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2)…

For More Information